Investigator Site 2

New York, New York 10032

0 studies enrolling now · 1 studies all time

What they study most

FSGS

Studies at this site

• A Sequential Phase 2/3 Study of APL2 in Patients With Focal Segmental Glomerulosclerosis — Paused